New therapeutic strategies for type 2 diabetes : small molecule approaches /
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Cambridge :
Royal Society of Chemistry,
[2012]
|
| Series: | RSC drug discovery series ;
27. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Type 2 diabetes: disease overview / Daniel M. Kemp
- Marketed small molecule dipeptidyl peptidase IV (DPP4) inhibitors as a new class of oral anti-diabetics / Zhonghua Pei
- SGLT2 inhibitors in development / William N. Washburn
- Glucokinase activators in development / Kevin J. Filipski, Benjamin D. Stevens and Jeffrey A. Pfefferkorn
- 11[beta]-hydroxysteroid dehydrogenase type 1 (11[beta]-HSD1) inhibitors in development / James S. Scott and Jasen Chooramun
- Recent advances in PTP1B inhibitor development for the treatment of type 2 diabetes and obesity / Rongjun He, Li-Fan Zeng, Yantao He and Zhong-Yin Zhang
- Recent advances in the discovery of GPR119 agonists / Unmesh Shah, Scott Edmondson and Jason W. Szewczyk
- Acyl-CoA: diacylglycerol acyltransferase-1 inhibition as an approach to the treatment of type 2 diabetes / Robert L. Dow
- Stearoyl-CoA desaturase 1 (SCD1) inhibitors: bench to bedside must only go through liver / Gang Liu
- TGR5 agonists in development / Antonio Macchiarulo, Antimo Gioiello and Roberto Pellicciari
- The discovery and development of MB07803, a second generation fructose-1,6-bisphosphatase inhibitor with improved pharmacokinetic properties, as a potential treatment of type 2 diabetes / Qun Dang, Paul D. van Poelje and Mark D. Erion
- Inhibition of glycogen phosphorylase as a strategy for the treatment of type 2 diabetes / Brad R. Henke
- SIRT1 activators in development / Robert B. Perni [and others]
- Long-chain free fatty acid receptor agonists / Jonathan B. Houze
- Glucagon receptor antagonists in development / Duane E. DeMong and M.W. Miller
- ACC inhibitors in development / Matthew P. Bourbeau.